GRAND PHARM. GRP. HD-01

GRAND PHARM. GRP. HD-01

MX6A · F · Healthcare / Drug Manufacturers - Specialty & Generic

0.476EUR+0.00 (+0.85%)

Price History

Full chart

Market Stats

Previous Close0.472
Open0.476
Day Range0.476 – 0.476
52-Week Range0.484 – 0.9214
Volume0
Market Cap1.85B
P/E (TTM)12.75
Forward P/E0.00
EPS0.04
Dividend Yield3.67%
Beta0.68
50-Day Avg0.5324
200-Day Avg0.6497

About

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine, and health food products. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company has a strategic partnership with the University of Hong Kong for the research and development of drugs in the field of anti-infection and the industrialization of the research results. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Chao Zhou
  • Employees12.33K
  • HeadquartersThe Center, Central, Hong Kong, Germany
  • Websitehttps://www.grandpharm.com

Leadership

  • Dr. Weikun TangExecutive Chairman · b. 1986
  • Mr. Chao ZhouCEO & Executive Director · b. 1990
  • Mr. Guang YangExecutive Director · b. 1977
  • Ms. Chit Yee LamExecutive Director · b. 1966
  • Liu HuInvestor Relations Director
  • Mr. Tin Chung Foo CPA (Aust.), HKICPACompany Secretary · b. 1969
  • Mr. Xiaofeng ShiChairman of Grand Pharm (China) · b. 1967
  • Xiaojie ChenVice President

Financials

Income Statement

Currency: HKD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.60B9.56B10.53B11.64B12.28B
Growth (%)-+11.22%+10.12%+10.59%+5.48%
Cost of Revenue3.35B3.61B4.01B4.91B5.50B
Gross Profit5.25B5.95B6.52B6.74B6.78B
Gross Margin61.03%62.24%61.96%57.86%55.20%
Operating Expense3.23B3.27B3.70B4.57B5.10B
Operating Income2.01B2.68B2.82B2.17B1.68B
Operating Margin23.43%28.06%26.81%18.65%13.71%
EBITDA-3.05B2.94B3.54B2.24B
EBITDA Margin-31.89%27.94%30.37%18.22%
Net Income2.40B2.08B1.88B2.47B1.24B
Net Income Margin27.94%21.75%17.85%21.20%10.10%
Interest Expense92.96M137.49M205.15M180.24M162.34M
Interest Expense % of Total Revenue1.08%1.44%1.95%1.55%1.32%

Balance Sheet

Currency: HKD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets21.06B22.37B22.52B24.99B27.17B
Total Liabilities7.61B8.16B7.24B8.47B9.99B
Total Equity13.39B14.14B15.16B16.47B17.02B
Cash1.75B1.44B1.34B1.34B1.14B
Net Debt1.87B2.96B1.97B3.04B3.53B

Cash Flow

Currency: HKD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.01B1.84B2.42B1.90B1.65B
Capital Expenditure536.37M1.09B497.69M621.88M1.52B
Free Cash Flow1.47B757.60M1.93B1.28B127.42M
Dividends Paid390.45M390.45M496.94M910.47M910.47M
FCF to OCF73.26%41.11%79.48%67.24%7.72%
Dividend Paid to FCF26.57%51.54%25.79%71.34%714.56%

Earnings

Report DateMar 25, 2027
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap1.85B
Enterprise Value2.21B
Trailing P/E12.75
Forward P/E0.00
Price / Sales0.15
Price / Book0.97
EPS0.04
Book Value0.5403
Revenue (TTM)12.48B
Gross Profit (TTM)6.49B
EBITDA2.30B
Profit Margin8.89%
Operating Margin18.19%
Return on Equity6.41%
Return on Assets3.88%
Shares Outstanding3.50B
Shares Float1.26B
Beta0.68
Dividend Yield3.67%
Dividend Rate0.02
Payout Ratio53.35%

Dividends

20261×
0.02Jun 12, 2026
20251×
0.03Apr 14, 2025
20241×
0.03Jun 6, 2024
20231×
0.02Jun 9, 2023
20221×
0.01Jun 6, 2022